Heart Test Laboratories Stock Shares Outstanding
| HSCS Stock | USD 5.60 0.03 0.53% |
Heart Test Laboratories fundamentals help investors to digest information that contributes to Heart Test's financial success or failures. It also enables traders to predict the movement of Heart Stock. The fundamental analysis module provides a way to measure Heart Test's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heart Test stock.
Common Stock Shares Outstanding is likely to drop to about 8.7 M in 2024. Heart | Shares Outstanding |
Heart Test Laboratories Company Shares Outstanding Analysis
Heart Test's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Heart Test Shares Outstanding | 655.62 K |
Most of Heart Test's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heart Test Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Heart Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Heart Test is extremely important. It helps to project a fair market value of Heart Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Heart Test's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heart Test's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heart Test's interrelated accounts and indicators.
Click cells to compare fundamentals
Heart Shares Outstanding Historical Pattern
Today, most investors in Heart Test Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Heart Test's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Heart Test shares outstanding as a starting point in their analysis.
Heart Test Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Heart Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Heart Test Laboratories has 655.62 K of shares currently outstending. This is 99.64% lower than that of the Health Care Equipment & Supplies sector and 99.63% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.89% higher than that of the company.
Heart Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heart Test's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics of similar companies.Heart Test is currently under evaluation in shares outstanding category among related companies.
Heart Test ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Heart Test's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Heart Test's managers, analysts, and investors.Environmental | Governance | Social |
Heart Fundamentals
| Return On Equity | -1.53 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (103.77) % | ||||
| Current Valuation | (2.16 M) | ||||
| Shares Outstanding | 655.62 K | ||||
| Shares Owned By Insiders | 16.00 % | ||||
| Shares Owned By Institutions | 2.37 % | ||||
| Number Of Shares Shorted | 617.59 K | ||||
| Price To Book | 0.81 X | ||||
| Price To Sales | 377.16 X | ||||
| Revenue | 5.15 K | ||||
| Gross Profit | 2.35 K | ||||
| EBITDA | (6.08 M) | ||||
| Net Income | (6.35 M) | ||||
| Cash And Equivalents | 4.27 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.57 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 13.57 X | ||||
| Cash Flow From Operations | (5.77 M) | ||||
| Short Ratio | 0.26 X | ||||
| Earnings Per Share | (35.00) X | ||||
| Target Price | 67.5 | ||||
| Number Of Employees | 12 | ||||
| Market Capitalization | 3.86 M | ||||
| Total Asset | 3.29 M | ||||
| Retained Earnings | (60.76 M) | ||||
| Working Capital | 863.69 K | ||||
| Net Asset | 3.29 M |
About Heart Test Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heart Test Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heart Test using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heart Test Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Heart Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Heart Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Heart Stock
| 0.68 | FEMY | Femasys | PairCorr |
Moving against Heart Stock
| 0.75 | WGS | GeneDx Holdings Corp | PairCorr |
| 0.68 | RMD | ResMed Inc Financial Report 1st of August 2024 | PairCorr |
| 0.6 | GCTK | GlucoTrack | PairCorr |
The ability to find closely correlated positions to Heart Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Heart Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Heart Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Heart Test Laboratories to buy it.
The correlation of Heart Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Heart Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Heart Test Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Heart Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Heart Test Piotroski F Score and Heart Test Altman Z Score analysis. Note that the Heart Test Laboratories information on this page should be used as a complementary analysis to other Heart Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Heart Stock analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Heart Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heart Test. If investors know Heart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heart Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (35.00) | Revenue Per Share 0.087 | Quarterly Revenue Growth 6.538 | Return On Assets (0.53) | Return On Equity (1.53) |
The market value of Heart Test Laboratories is measured differently than its book value, which is the value of Heart that is recorded on the company's balance sheet. Investors also form their own opinion of Heart Test's value that differs from its market value or its book value, called intrinsic value, which is Heart Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heart Test's market value can be influenced by many factors that don't directly affect Heart Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heart Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heart Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heart Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.